Confluence Investment Management Has Lifted W.R. Berkley Corp. (WRB) Position; Gyroscope Capital Management Group Has Boosted Its Cvs Health (CVS) Position

W. R. Berkley Corporation (NYSE:WRB) Logo

Gyroscope Capital Management Group Llc increased Cvs Health Corp (CVS) stake by 64.58% reported in 2018Q1 SEC filing. Gyroscope Capital Management Group Llc acquired 39,896 shares as Cvs Health Corp (CVS)’s stock declined 3.22%. The Gyroscope Capital Management Group Llc holds 101,678 shares with $6.33M value, up from 61,782 last quarter. Cvs Health Corp now has $69.55 billion valuation. The stock increased 3.10% or $2.06 during the last trading session, reaching $68.41. About 13.83M shares traded or 58.35% up from the average. CVS Health Corporation (NYSE:CVS) has declined 13.06% since June 14, 2017 and is downtrending. It has underperformed by 25.63% the S&P500. Some Historical CVS News: ; 06/03/2018 – S&PGR Downgrades CVS Health To ‘BBB’; Debt Rated ‘BBB’; 14/05/2018 – Old Mutual Adds eBay, Exits CVS, Cuts Nvidia: 13F; 04/05/2018 – WSVN 7 News: #BREAKING: Jury decides to not press charges in 2017’s fatal CVS shooting in Davie; 13/04/2018 – CVS Health Names Marc-David Munk, MD, MPH, MHCM, as Chief Medical Officer of MinuteClinic and Associate Chief Medical Officer of CVS Health; 13/03/2018 – Aetna Hldrs Overwhelmingly Approve Proposed Acquisition by CVS Health; 02/05/2018 – CVS Health Sees 2Q EPS $1.21-EPS $1.26; 11/05/2018 – CVS HEALTH COMMENTS ON TRUMP INITIATIVE TO CUT DRUG COSTS; 07/05/2018 – FRED’S INC – REACHED AGREEMENT TO SELL CERTAIN ASSETS OF ENTRUSTRX TO A SUBSIDIARY OF CVS HEALTH CORP; 06/03/2018 – CVS Health Expands Safe Drug Disposal at CVS Pharmacy Locations in Rhode Island to Help Combat Opioid Abuse; 14/03/2018 – CVS and Walgreens hope that by helping people pick up their prescriptions, they can boost the rates of people taking their drugs, improve patient outcomes and ultimately lower costs

Confluence Investment Management Llc increased W.R. Berkley Corp. (WRB) stake by 2.81% reported in 2018Q1 SEC filing. Confluence Investment Management Llc acquired 13,073 shares as W.R. Berkley Corp. (WRB)’s stock rose 9.47%. The Confluence Investment Management Llc holds 477,786 shares with $34.74 million value, up from 464,713 last quarter. W.R. Berkley Corp. now has $9.31B valuation. The stock decreased 0.58% or $0.45 during the last trading session, reaching $76.55. About 388,164 shares traded or 3.02% up from the average. W. R. Berkley Corporation (NYSE:WRB) has risen 13.74% since June 14, 2017 and is uptrending. It has outperformed by 1.17% the S&P500. Some Historical WRB News: ; 10/05/2018 – MOODY’S UPGRADES W.R. BERKLEY SR DEBT TO Baa1, OUTLOOK STABLE; 23/04/2018 – DJ W R Berkley Corporation, Inst Holders, 1Q 2018 (WRB); 19/03/2018 – W. R. Berkley Corporation Announces Pricing of $175 Million of 5.70% Subordinated Debentures Due 2058; 19/03/2018 – A.M. Best Assigns Issue Credit Rating to W. R. Berkley Corporation’s Subordinated Debentures; 25/04/2018 – W. R. BERKLEY CORP WRB.N : RBC RAISES TARGET PRICE TO $76 FROM $74; 20/03/2018 – Moody’s Assigns W.R. Berkley’s Shelf Ratings; Rates Subordinated Notes Baa3(hyb), On Review For Upgrade; 15/05/2018 – Berkley WR Corp. Exits Position in Global Partner Acquisition; 24/04/2018 – W. R. BERKLEY CORP – NET PREMIUMS WRITTEN IN INSURANCE SEGMENT GREW BY 3.3% IN QUARTER; 24/04/2018 – WR BERKLEY 1Q REV. $1.89B, EST. $1.86B (2 EST.); 19/04/2018 – W. R. Berkley Corp Announces Senior Executive Appointments

Another recent and important W. R. Berkley Corporation (NYSE:WRB) news was published by which published an article titled: “AM Best Affirms Credit Ratings of WR Berkley Corporation and Its Subsidiaries” on May 24, 2018.

Confluence Investment Management Llc decreased Stryker Corp. (NYSE:SYK) stake by 26,995 shares to 526,180 valued at $84.67M in 2018Q1. It also reduced 3M Company (NYSE:MMM) stake by 4,243 shares and now owns 481,060 shares. Graco Inc. (NYSE:GGG) was reduced too.

Among 10 analysts covering W.R. Berkley (NYSE:WRB), 1 have Buy rating, 1 Sell and 8 Hold. Therefore 10% are positive. W.R. Berkley has $7600 highest and $52 lowest target. $66’s average target is -13.78% below currents $76.55 stock price. W.R. Berkley had 24 analyst reports since July 28, 2015 according to SRatingsIntel. The stock of W. R. Berkley Corporation (NYSE:WRB) earned “Outperform” rating by Macquarie Research on Tuesday, January 17. On Thursday, July 6 the stock rating was maintained by Keefe Bruyette & Woods with “Hold”. The stock of W. R. Berkley Corporation (NYSE:WRB) has “Hold” rating given on Wednesday, October 4 by Keefe Bruyette & Woods. The stock of W. R. Berkley Corporation (NYSE:WRB) has “Neutral” rating given on Tuesday, October 13 by Compass Point. The company was maintained on Wednesday, October 25 by UBS. RBC Capital Markets maintained W. R. Berkley Corporation (NYSE:WRB) rating on Wednesday, January 31. RBC Capital Markets has “Hold” rating and $74.0 target. Keefe Bruyette & Woods maintained W. R. Berkley Corporation (NYSE:WRB) on Thursday, December 21 with “Hold” rating. The rating was maintained by RBC Capital Markets with “Sector Perform” on Tuesday, July 28. The firm has “Hold” rating given on Wednesday, October 25 by Deutsche Bank. The stock has “Neutral” rating by Bank of America on Wednesday, October 25.

Among 26 analysts covering CVS Health (NYSE:CVS), 19 have Buy rating, 0 Sell and 7 Hold. Therefore 73% are positive. CVS Health has $132 highest and $73 lowest target. $96.05’s average target is 40.40% above currents $68.41 stock price. CVS Health had 77 analyst reports since July 22, 2015 according to SRatingsIntel. The firm has “Neutral” rating by Atlantic Securities given on Monday, February 6. Needham upgraded the stock to “Buy” rating in Friday, November 10 report. Leerink Swann maintained it with “Buy” rating and $85.0 target in Tuesday, November 21 report. As per Tuesday, November 7, the company rating was maintained by Leerink Swann. The firm earned “Buy” rating on Monday, December 4 by Needham. As per Friday, December 18, the company rating was initiated by Barclays Capital. The rating was maintained by Jefferies on Tuesday, November 7 with “Hold”. Needham maintained the stock with “Buy” rating in Tuesday, January 2 report. On Thursday, March 10 the stock rating was reinitiated by Barclays Capital with “Overweight”. The rating was maintained by Robert W. Baird with “Hold” on Friday, October 27.

More notable recent CVS Health Corporation (NYSE:CVS) news were published by: which released: “Time Warner-AT&T deal could pave way for CVS-Aetna acquisition” on June 13, 2018, also with their article: “What the Management Picture for CVS and Aetna Will Look Like Going Forward” published on June 06, 2018, published: “Why The Huge AT&T Win May Bode Well For Other Takeover Targets” on June 13, 2018. More interesting news about CVS Health Corporation (NYSE:CVS) were released by: and their article: “The Case To Own Both Aetna And CVS Health” published on June 11, 2018 as well as‘s news article titled: “Fred’s completes sale of Specialty Pharmacy unit” with publication date: June 04, 2018.

W. R. Berkley Corporation (NYSE:WRB) Institutional Positions Chart